• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡罗昔康-聚乙烯吡咯烷酮老化固体分散体的研究

Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.

作者信息

Ingkatawornwong S, Kaewnopparat N, Tantishaiyakul V

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Songkhla, Thailand.

出版信息

Pharmazie. 2001 Mar;56(3):227-30.

PMID:11265589
Abstract

The stabilities of X-ray amorphous solid dispersions of piroxicam and polyvinylpyrrolidone (PVP) K-17 and PVP K-30 (1:5 and 1:4), respectively, were investigated after storage for 12 months. X-ray diffraction showed that in the aged solid dispersions piroxicam remained in the amorphous state. Fourier transform infrared (FTIR) spectroscopy indicated that the interactions between drug and PVP in aged solid dispersions are similar to those in freshly prepared samples. The dissolution rates of the X-ray amorphous solid dispersions during storage for 12 months at 45 degrees C and ambient temperature were examined. Very minor decreases in dissolution rates of aged solid dispersions were found which might be due to the coarsening of the particles. Dissolutions of these amorphous solid dispersions after aging for 12 months still showed an about 40-fold increase in dissolution in 5 min compared to pure drug.

摘要

分别研究了吡罗昔康与聚乙烯吡咯烷酮(PVP)K-17和PVP K-30(比例分别为1:5和1:4)形成的X射线非晶态固体分散体在储存12个月后的稳定性。X射线衍射表明,在老化的固体分散体中,吡罗昔康仍处于非晶态。傅里叶变换红外(FTIR)光谱表明,老化固体分散体中药物与PVP之间的相互作用与新鲜制备样品中的相似。考察了X射线非晶态固体分散体在45℃和室温下储存12个月期间的溶出速率。发现老化固体分散体的溶出速率有非常轻微的下降,这可能是由于颗粒粗化所致。这些非晶态固体分散体老化12个月后的溶出度与纯药物相比,在5分钟内仍显示出约40倍的增加。

相似文献

1
Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.吡罗昔康-聚乙烯吡咯烷酮老化固体分散体的研究
Pharmazie. 2001 Mar;56(3):227-30.
2
Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.吡罗昔康在聚乙烯吡咯烷酮中的固体分散体性质
Int J Pharm. 1999 Apr 30;181(2):143-51. doi: 10.1016/s0378-5173(99)00070-8.
3
Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.采用球形结晶技术制备并评价吡罗昔康与 Eudragit S100 的固体分散体。
Drug Dev Ind Pharm. 2010 Aug;36(8):917-25. doi: 10.3109/03639040903585127.
4
Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.难溶性药物在聚甲基丙烯酸2-羟乙酯水凝胶中的固体分子分散体。
Eur J Pharm Biopharm. 2007 Mar;65(3):320-8. doi: 10.1016/j.ejpb.2006.10.025. Epub 2006 Dec 19.
5
Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.吡罗昔康-烟酰胺固体分散体剂型的溶出度、生物利用度及致溃疡研究
Boll Chim Farm. 2003 Apr;142(3):119-24.
6
Characterization and stability of solid dispersions based on PEG/polymer blends.基于 PEG/聚合物共混物的固体分散体的特性和稳定性。
Int J Pharm. 2010 May 10;390(2):165-73. doi: 10.1016/j.ijpharm.2010.01.039. Epub 2010 Feb 10.
7
Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.吲哚美辛/PVP固体分散体肠溶微粒的拉曼光谱与热分析
Eur J Pharm Biopharm. 2008 Sep;70(1):409-20. doi: 10.1016/j.ejpb.2008.03.016. Epub 2008 Apr 8.
8
A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.喷雾干燥和粉碎在磺胺噻唑/聚乙烯吡咯烷酮和磺胺嘧啶/聚乙烯吡咯烷酮无定形分散体制备中的比较。
Mol Pharm. 2011 Apr 4;8(2):532-42. doi: 10.1021/mp1003674. Epub 2011 Mar 3.
9
Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.含吡罗昔康的半固体分散体在硬明胶胶囊中的物理稳定性评估与增强
Acta Pol Pharm. 2013 Sep-Oct;70(5):883-97.
10
Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.新型脂质制剂增强了难溶性模型药物吡罗昔康的体外溶出度和通透性特征。
Int J Pharm. 2005 Sep 14;301(1-2):209-16. doi: 10.1016/j.ijpharm.2005.05.032.

引用本文的文献

1
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.用于无定形固体分散体剂型开发的热熔挤出风险评估分类系统
Pharmaceutics. 2022 May 12;14(5):1044. doi: 10.3390/pharmaceutics14051044.